ING Groep NV Makes New Investment in HCA Healthcare, Inc. $HCA

ING Groep NV acquired a new stake in HCA Healthcare, Inc. (NYSE:HCA) in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 2,405 shares of the company’s stock, valued at approximately $1,025,000.

Other institutional investors have also modified their holdings of the company. Sovran Advisors LLC boosted its holdings in HCA Healthcare by 1.0% in the third quarter. Sovran Advisors LLC now owns 2,278 shares of the company’s stock valued at $1,063,000 after purchasing an additional 22 shares during the period. Centerpoint Advisors LLC boosted its stake in shares of HCA Healthcare by 11.0% in the 3rd quarter. Centerpoint Advisors LLC now owns 222 shares of the company’s stock valued at $95,000 after buying an additional 22 shares during the period. Hemington Wealth Management raised its holdings in HCA Healthcare by 11.0% in the third quarter. Hemington Wealth Management now owns 253 shares of the company’s stock valued at $107,000 after acquiring an additional 25 shares in the last quarter. Abound Wealth Management increased its position in shares of HCA Healthcare by 28.0% in the 3rd quarter. Abound Wealth Management now owns 119 shares of the company’s stock valued at $51,000 after purchasing an additional 26 shares during the last quarter. Finally, Annis Gardner Whiting Capital Advisors LLC lifted its position in shares of HCA Healthcare by 17.1% during the 3rd quarter. Annis Gardner Whiting Capital Advisors LLC now owns 185 shares of the company’s stock worth $79,000 after purchasing an additional 27 shares during the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Buying and Selling

In related news, SVP Jennifer Berres sold 8,020 shares of the firm’s stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $514.58, for a total value of $4,126,931.60. Following the completion of the sale, the senior vice president owned 11,993 shares in the company, valued at $6,171,357.94. This trade represents a 40.07% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, EVP Michael S. Cuffe sold 1,500 shares of the business’s stock in a transaction that occurred on Tuesday, February 3rd. The stock was sold at an average price of $498.09, for a total value of $747,135.00. Following the transaction, the executive vice president owned 30,003 shares in the company, valued at $14,944,194.27. The trade was a 4.76% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold 13,520 shares of company stock valued at $6,894,067 over the last ninety days. Corporate insiders own 1.30% of the company’s stock.

HCA Healthcare Stock Performance

Shares of NYSE:HCA opened at $539.91 on Friday. HCA Healthcare, Inc. has a one year low of $295.00 and a one year high of $552.90. The company has a 50-day simple moving average of $482.80 and a 200-day simple moving average of $448.96. The stock has a market capitalization of $120.73 billion, a price-to-earnings ratio of 19.02, a PEG ratio of 1.66 and a beta of 1.36.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Tuesday, January 27th. The company reported $8.01 EPS for the quarter, beating the consensus estimate of $7.37 by $0.64. The firm had revenue of $19.51 billion during the quarter, compared to the consensus estimate of $19.67 billion. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.The firm’s revenue was up 6.7% compared to the same quarter last year. During the same period in the prior year, the business earned $6.22 EPS. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. As a group, research analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 31st. Stockholders of record on Tuesday, March 17th will be paid a $0.78 dividend. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.72. The ex-dividend date is Tuesday, March 17th. This represents a $3.12 annualized dividend and a dividend yield of 0.6%. HCA Healthcare’s dividend payout ratio (DPR) is 10.15%.

Wall Street Analyst Weigh In

A number of analysts have issued reports on the company. The Goldman Sachs Group lifted their price target on HCA Healthcare from $520.00 to $558.00 and gave the stock a “buy” rating in a report on Wednesday, January 28th. Mizuho set a $540.00 price target on HCA Healthcare in a report on Monday, February 2nd. Royal Bank Of Canada boosted their price objective on shares of HCA Healthcare from $525.00 to $555.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 28th. Wells Fargo & Company lifted their price target on shares of HCA Healthcare from $452.00 to $481.00 and gave the stock an “equal weight” rating in a research note on Friday, January 30th. Finally, Weiss Ratings reaffirmed a “buy (b)” rating on shares of HCA Healthcare in a report on Monday, December 29th. Sixteen research analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $523.27.

Key Headlines Impacting HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: HCA’s share performance is strong on a year‑over‑year basis (shares up ~75% YoY), reinforcing momentum and investor confidence in the company’s results and outlook. Read More.
• Positive Sentiment: Zacks and other analysts highlight earnings growth and price strength; Zacks added HCA to focus coverage and raised FY‑2026 EPS estimates, supporting forward earnings momentum and valuation. Read More.
• Positive Sentiment: HCA raised its quarterly dividend (new quarterly payout announced), which narrows yield risk and is a modest positive for income‑oriented investors. Read More.
• Positive Sentiment: Large institutional flows and stake increases (e.g., Norges Bank, Pacer, Viking Global) point to strong institutional demand and provide technical/supportive buying pressure for the stock. Read More.
• Neutral Sentiment: HCA completed a 43‑hospital EHR rollout and is tracking success metrics — operational execution that can improve efficiency and integration over time but has a gradual, not immediate, earnings impact. Read More.
• Neutral Sentiment: Local expansion moves — HCA Houston Healthcare Tomball acquired Supreme Care ER and StoneSprings plans a freestanding ER conversion — small, market‑level capacity adds that could modestly lift volumes in those geographies. Read More.
• Neutral Sentiment: HCA sold ASC real estate — a financing/portfolio move that could free capital or change lease terms; impact depends on transaction use of proceeds. Read More.
• Negative Sentiment: Insider selling: two senior VPs disclosed multi‑million dollar sales (Christopher Wyatt sold ~$2.0M; Jennifer Berres sold ~$4.13M). Significant insider sales can create short‑term selling pressure or raise governance/portfolio‑rebalancing questions. Read More. Read More.
• Negative Sentiment: Zacks/other outlets flagged a downward revision to HCA’s Q1 EPS forecast, which can pressure near‑term expectations even as FY estimates were raised. Read More.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.